VitalStone Financial’s Xylem XYL Stock Holding History

VitalStone Financial’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-56	Closed	-$7.59K	–	557
2024 Q2	$7.59K	Buy	+56	New	+$7.62K	0.01%	297
2023 Q4	–	Sell	-70	Closed	-$7K	–	608
2023 Q3	$7K	Buy	+70	New	+$7.22K	0.01%	283

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

VitalStone Financial's XYL Position: Q3 2024 in Review

VitalStone Financial sold out of Xylem (XYL) in Q3 2024, closing a stake of 56 shares — an estimated $7.59K sold.

VitalStone Financial first reported a position in XYL in Q3 2023 and held it in 2 quarters. The position peaked at $7.59K in Q2 2024. 1,017 funds tracked by Wall St. Rank hold XYL as of Q3 2024.

VitalStone Financial reported no remaining Xylem position as of Q3 2024 after selling out during the quarter.
VitalStone Financial sold 56 Xylem shares in Q3 2024, an estimated $7.59K.
VitalStone Financial first reported a position in Xylem in Q3 2023 and held it in 2 quarters.
VitalStone Financial's Xylem position peaked at $7.59K in Q2 2024.
1,017 funds tracked by Wall St. Rank held Xylem as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.